151 related articles for article (PubMed ID: 32414469)
1. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
4. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
Hiblu MA; Khabuli NM; Gaja AO
Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
Scarpelli KC; Valladão ML; Metze K
Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
[TBL] [Abstract][Full Text] [Related]
6. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
7. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
8. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
[TBL] [Abstract][Full Text] [Related]
9. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
10. Vincristine for treatment of transmissible venereal tumor in the dog--.
Calvert CA; Leifer CE; MacEwen EG
J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
[No Abstract] [Full Text] [Related]
11. Transmissible venereal tumor: a retrospective study of 29 cases.
Rogers KS; Walker MA; Dillon HB
J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
[TBL] [Abstract][Full Text] [Related]
12. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
Nak D; Nak Y; Cangul IT; Tuna B
J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
Brown NO; Calvert C; MacEwen EG
J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
[TBL] [Abstract][Full Text] [Related]
15. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-associated total antioxidant and oxidant status of ovaries and in vitro nuclear oocyte maturation in dogs with canine transmissible venereal tumor.
Özalp GR; Üstüner B; Avci G; Bari Ö; Yılmaz MM; Denk B; Aktar A
Anim Reprod Sci; 2023 Jun; 253():107260. PubMed ID: 37196377
[TBL] [Abstract][Full Text] [Related]
17. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
Amber EI; Henderson RA
J Vet Intern Med; 1992; 6(5):300. PubMed ID: 1432905
[No Abstract] [Full Text] [Related]
18. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
Amber EI; Henderson RA; Adeyanju JB; Gyang EO
J Vet Intern Med; 1990; 4(3):144-7. PubMed ID: 2366223
[TBL] [Abstract][Full Text] [Related]
19. Theriogenology question of the month. Transmissible venereal tumor (TVT).
Hasler AH; Weber WT
J Am Vet Med Assoc; 2000 May; 216(10):1557-9. PubMed ID: 10825939
[No Abstract] [Full Text] [Related]
20. Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor.
Frampton D; Schwenzer H; Marino G; Butcher LM; Pollara G; Kriston-Vizi J; Venturini C; Austin R; de Castro KF; Ketteler R; Chain B; Goldstein RA; Weiss RA; Beck S; Fassati A
Cancer Cell; 2018 Apr; 33(4):620-633.e6. PubMed ID: 29634949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
